Brent Rutland
Chief Tech/Sci/R&D Officer chez KORU MEDICAL SYSTEMS, INC.
Profil
Brent Rutland is currently the Vice President-Medical Affairs at KORU Medical Systems, Inc. Prior to this, he worked as the Senior Director-Health Outcomes at La Jolla Pharmaceutical Co. from 2018 to 2022.
He also served as the Senior Medical Science Liaison at Baxter International, Inc. from 2016 to 2017.
Mr. Rutland completed his undergraduate degree at Texas A&M University and holds an MBA from the University of Houston.
He also obtained a graduate degree from the University of North Carolina at Chapel Hill.
Postes actifs de Brent Rutland
| Sociétés | Poste | Début |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Brent Rutland
| Sociétés | Poste | Fin |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01/10/2022 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2017 |
Formation de Brent Rutland
| Texas A&M University | Undergraduate Degree |
| University of Houston | Masters Business Admin |
| University of North Carolina at Chapel Hill | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| KORU MEDICAL SYSTEMS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
